William E. Dowling

2.0k total citations
18 papers, 736 citations indexed

About

William E. Dowling is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, William E. Dowling has authored 18 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 5 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in William E. Dowling's work include Viral gastroenteritis research and epidemiology (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV Research and Treatment (5 papers). William E. Dowling is often cited by papers focused on Viral gastroenteritis research and epidemiology (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and HIV Research and Treatment (5 papers). William E. Dowling collaborates with scholars based in United States, Germany and Kenya. William E. Dowling's co-authors include Erich R. Mackow, Francine E. McCutchan, Deborah L. Birx, Merlin L. Robb, Jean K. Carr, Robert D. Shaw, Connie S. Schmaljohn, E. Ashley Thompson, Aura R. Garrison and Jeffery M. Smith and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Virology.

In The Last Decade

William E. Dowling

18 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Dowling United States 13 480 250 154 149 96 18 736
Antonio Más Spain 21 599 1.2× 527 2.1× 347 2.3× 215 1.4× 84 0.9× 87 1.2k
Denys Brand France 20 401 0.8× 478 1.9× 201 1.3× 410 2.8× 240 2.5× 41 1.1k
Lee Jy Australia 12 266 0.6× 113 0.5× 138 0.9× 438 2.9× 89 0.9× 30 807
Elena Giorgi United States 17 651 1.4× 744 3.0× 288 1.9× 327 2.2× 246 2.6× 43 1.3k
Eva Mittler United States 16 750 1.6× 99 0.4× 106 0.7× 332 2.2× 99 1.0× 25 976
Kshitij Wagh United States 16 568 1.2× 489 2.0× 294 1.9× 121 0.8× 281 2.9× 28 1.1k
Dorota Kmieć Germany 13 358 0.7× 347 1.4× 304 2.0× 219 1.5× 253 2.6× 28 814
Monica Sala France 17 368 0.8× 454 1.8× 279 1.8× 184 1.2× 219 2.3× 39 894
Matthijs R. A. Welkers Netherlands 13 292 0.6× 182 0.7× 181 1.2× 291 2.0× 71 0.7× 36 644
B. J. Potts United States 9 414 0.9× 625 2.5× 213 1.4× 173 1.2× 248 2.6× 14 850

Countries citing papers authored by William E. Dowling

Since Specialization
Citations

This map shows the geographic impact of William E. Dowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Dowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Dowling more than expected).

Fields of papers citing papers by William E. Dowling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Dowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Dowling. The network helps show where William E. Dowling may publish in the future.

Co-authorship network of co-authors of William E. Dowling

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Dowling. A scholar is included among the top collaborators of William E. Dowling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Dowling. William E. Dowling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sitaras, Ioannis, Henning Jacobsen, Melissa M. Higdon, et al.. (2022). Systematic review of primary and booster COVID-19 sera neutralizing ability against SARS-CoV-2 omicron variant. npj Vaccines. 7(1). 147–147. 10 indexed citations
2.
Taylor, Kimberly L., Lynda Lanning, Lawrence A. Wolfraim, et al.. (2022). A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine Development. Vaccines. 10(8). 1201–1201. 4 indexed citations
3.
Finch, Courtney L., William E. Dowling, Ramon Roozendaal, et al.. (2022). Bridging Animal and Human Data in Pursuit of Vaccine Licensure. Vaccines. 10(9). 1384–1384. 8 indexed citations
4.
Kumar, Arun, William E. Dowling, Raúl Gómez Román, et al.. (2021). Status Report on COVID-19 Vaccines Development. Current Infectious Disease Reports. 23(6). 9–9. 53 indexed citations
5.
Prescott, Mark J., Carolyn E. Clark, William E. Dowling, & Amy C. Shurtleff. (2021). Opportunities for Refinement of Non-Human Primate Vaccine Studies. Vaccines. 9(3). 284–284. 4 indexed citations
6.
Funnell, Simon G. P., William E. Dowling, César Muñoz‐Fontela, et al.. (2020). Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients. Nature Communications. 11(1). 4253–4253. 37 indexed citations
7.
DeWald, Lisa Evans, Joshua C. Johnson, Elena Postnikova, et al.. (2019). In Vivo Activity of Amodiaquine against Ebola Virus Infection. Scientific Reports. 9(1). 20199–20199. 13 indexed citations
8.
DiCarlo, Andrea L., David R. Cassatt, William E. Dowling, et al.. (2018). Challenges and Benefits of Repurposing Products for Use during a Radiation Public Health Emergency: Lessons Learned from Biological Threats and other Disease Treatments. Radiation Research. 190(6). 659–659. 30 indexed citations
9.
Ghatak, Shibnath, Roger R. Markwald, Vincent Hascall, et al.. (2017). Transforming growth factor β1 (TGFβ1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. Journal of Biological Chemistry. 292(25). 10465–10489. 37 indexed citations
10.
Tovanabutra, Sodsai, Jeffrey R. Currier, Josephine H. Cox, et al.. (2006). Circulating and Unique Recombinant Forms of HIV Type 1 Containing Subsubtype A2. AIDS Research and Human Retroviruses. 22(7). 695–702. 10 indexed citations
11.
Dowling, William E., E. Ashley Thompson, Catherine V. Badger, et al.. (2006). Influences of Glycosylation on Antigenicity, Immunogenicity, and Protective Efficacy of Ebola Virus GP DNA Vaccines. Journal of Virology. 81(4). 1821–1837. 108 indexed citations
12.
Currier, Jeffrey R., William E. Dowling, K. Wasunna, et al.. (2003). Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans. AIDS. 17(15). 2149–2157. 18 indexed citations
13.
Papathanasopoulos, Maria A., Tonie Cilliers, Lynn Morris, et al.. (2002). Full-Length Genome Analysis of HIV-1 Subtype C Utilizing CXCR4 and Intersubtype Recombinants Isolated in South Africa. AIDS Research and Human Retroviruses. 18(12). 879–886. 40 indexed citations
14.
Höelscher, Michael, William E. Dowling, Eric Sanders‐Buell, et al.. (2002). Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS. 16(15). 2055–2064. 86 indexed citations
15.
Dowling, William E., Bohye Kim, Carl J. Mason, et al.. (2002). Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS. 16(13). 1809–1820. 93 indexed citations
16.
Dowling, William E., et al.. (2001). VP4 Differentially Regulates TRAF2 Signaling, Disengaging JNK Activation while Directing NF-κB to Effect Rotavirus-specific Cellular Responses. Journal of Biological Chemistry. 276(23). 19889–19896. 45 indexed citations
17.
Dowling, William E., et al.. (2000). Selective Membrane Permeabilization by the Rotavirus VP5* Protein Is Abrogated by Mutations in an Internal Hydrophobic Domain. Journal of Virology. 74(14). 6368–6376. 64 indexed citations
18.
Dowling, William E., et al.. (1999). Rotavirus Capsid Protein VP5* Permeabilizes Membranes. Journal of Virology. 73(4). 3147–3153. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Más Breakdown of academic impact, for papers by Denys Brand Breakdown of academic impact, for papers by Lee Jy Breakdown of academic impact, for papers by Elena Giorgi Breakdown of academic impact, for papers by Eva Mittler Breakdown of academic impact, for papers by Kshitij Wagh Breakdown of academic impact, for papers by Dorota Kmieć Breakdown of academic impact, for papers by Monica Sala Breakdown of academic impact, for papers by Matthijs R. A. Welkers Breakdown of academic impact, for papers by B. J. Potts
Rankless by CCL
2026